At 22Neuro, we believe every brain deserves care that is precise, personalized, and accessible.
Our mission is to harness the power of AI, neuroscience, and human compassion to transform neurological care—making early diagnosis, preventive solutions, and personalized treatment a reality for millions.
Our vision is simple yet ambitious: to add life to years, not just years to life.
22Neuro is led by passionate pioneers at the intersection of healthcare, AI, and neuroscience.
Our Scientific Advisory Board guides our innovation with wisdom and rigor:
Eminent Neurologist, Apollo Hospitals, Nellore | Founder, Dr. Bindu Menon Foundation.
A leading voice in epilepsy, stroke, and AI in neurology, Prof. Menon brings decades of clinical expertise and a deep commitment to patient advocacy.
From that question, 22Neuro was born.
Conceived under Transcend Discoveries, we started as a data-engineering venture focused on decoding complex neurological signals.
Our founders brought together a unique blend of AI expertise, neurology practice, and clinical navigation to address the gap in neuro care.
Development of AI-powered diagnostics pipelines capable of rapid neurological screening.
Launch of tele-neuro and phygital clinics, enabling care in both urban centers and underserved rural communities.
Introduction of our flagship QEEG-based platform, making preventive and wellness-driven brain care a reality.
Strategic collaborations with hospitals and research institutions in India, US, EU, Australia, Korea, and the Middle East.
22Neuro now supports 1000+ clinics, targeting 10 crore+ patients, and expanding solutions to over 15 neurological conditions.
Our journey has only just begun. The road ahead is about scaling smarter, deeper, and wider, ensuring every brain gets the care it deserves.
Behind every data point is a human life. We design with empathy and deliver with dignity.
AI is not just technology—it is a tool to solve real-world neurological challenges.
Brain care should never be a privilege. We strive to bridge gaps across rural and urban healthcare.
We partner with doctors, researchers, and institutions worldwide, believing progress comes from collective intelligence.
Security, ethics, and transparency form the foundation of our clinical and technological practices.
Our focus is not only on treating disease but also on predicting, preventing, and preserving brain health for generations to come.
Serial MedTech Entrepreneur | Health Evangelist | Humanist
A MedTech AI leader specializing in neuro-navigation, Rajesh brings over two decades of experience in building technology that bridges neuroscience, AI, and clinical practice. His vision drives 22Neuro’s mission to deliver scalable, affordable brain care globally.
MBBS, MRCP (UK) – Endocrinology & Diabetes | MHA (Gold Medalist) | CHSE (USA) Consultant Physician • Clinical Simulation Expert • Health Systems Strategist
Dr. Anand Hinduja is a distinguished clinician and healthcare educator with over fifteen years of experience in Diabetes, Thyroid, Kidney, and Metabolic Disorders. Founder of Aarti Clinic®, he has built one of Navi Mumbai’s most advanced metabolic-health practices, integrating cutting-edge diagnostics—including continuous glucose monitoring analytics, muscle dynamometry, trichoscopy, food intolerance mapping, and patented sudomotor testing—to deliver precise, data-driven care.
A Certified Healthcare Simulation Educator (CHSE – USA) and Adjunct Faculty in Clinical Simulation at Symbiosis International University, Dr. Hinduja is nationally recognized for advancing simulation-based medical education. He has authored over 40+ publications, mentored healthcare professionals across India, and contributed significantly to curriculum development and research methodology in clinical training.
He is one of only two doctors selected from India for the Jumpstart Renal Nutrition Therapy Research Program 2024/25, reflecting his global academic footprint. His work has been presented at premier platforms including APICON, the International Diabetes Summit, Emergency Medicine Congresses, and the European Sleep Congress.
Leadership Role at 22Neuro
At 22Neuro, Dr. Anand Hinduja plays a pivotal strategic and clinical leadership role. He contributes not only as a physician but as a systems architect, clinical quality lead, and innovation advisor. His leadership spans:
Designing and standardising clinical pathways for metabolic, cognitive, and functional assessments.
Strengthening clinical governance through protocol development, audit frameworks, and outcome monitoring.
Integrating advanced diagnostics—including HRV-based assessments, metabolic profiling, and cognitive-screening tools—to elevate patient evaluation standards.
Shaping patient experience and communication frameworks grounded in empathy, accessibility, and clarity.
Building clinician capacity through simulation-based teaching, structured training modules, and faculty development.
Advising on growth strategy for multisite expansion, tiered centre models, partnerships, and technology adoption.
His diverse background in clinical medicine, simulation pedagogy, and healthcare consulting uniquely positions him as a core driving force behind 22Neuro’s commitment to safe, structured, and future-ready neurorehabilitation.
Beyond 22Neuro
Dr. Hinduja serves as Managing Director of Wellness Anchor Foundation, leads community initiatives such as Circle of Hope and Screen to Protect, and directs the CardioDiabetes Synergy Symposium, a national academic platform.
Dr. Dwarikanath Mahapatra is a Principal AI Scientist at LocAI, with deep expertise in computer vision, deep learning, and medical imaging. He holds a Ph.D. from the National University of Singapore and has held prestigious research positions including post-doctoral fellow at ETH Zurich, Research Staff Member at IBM Research Australia, and Senior Scientist at Inception AI in Abu Dhabi. His work focuses on applying AI to healthcare, particularly in medical image analysis, decision support systems, and computer-aided diagnosis. Dr. Mahapatra has extensive experience in developing and deploying AI solutions, especially Large Multimodal Models, and has led successful AI initiatives across industry and academia. He has authored over 130 publications in top-tier conferences and journals, holds 15 patents, and has been recognized among the top 2% of scientists globally and in the top 30 computer science researchers in the UAE. His accolades include four best paper awards and multiple honors from IBM Research, including two “Manager’s Choice Awards.” In addition to his research contributions, Dr. Mahapatra is a committed mentor and educator, having guided over 30 scientists, engineers, professionals, and PhD students. He actively serves the academic community as an editor and reviewer for leading journals (e.g., IEEE TMI, TAI) and conferences (e.g., MICCAI, MIDL, ISBI), and remains dedicated to shaping the next generation of AI professionals.